Mirvie

Series-B+
mirvie.com Biotech & Healthcare South San Francisco, United States Founded 2018 11-50
Total Funding $60M
Latest Round $60M Series-B+
Last Announced May 17, 2022
Investors 12 Backers
Decision Makers 6 Verified

About Mirvie

The Mirvie RNA platform is first to predict unexpected complications before they happen by revealing the underlying biology of each pregnancy

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters South San Francisco, United States
Year Founded 2018
Team Size 11-50
Tracked Since Oct 1, 2026

Web & Domain Identity

Official Website mirvie.com
Domain Registered Date Apr 17, 2019

Social & Network Presence

X / Twitter Profile @MirvieDx (461 followers) Created on Apr 2019
LinkedIn Corporate Not linked

Company Milestones & Timeline

4 Events
  1. Capital Raise

    Raised $60,000,000 · Series-B+

    fundraisingfox.com

  2. Milestone

    X account created (@MirvieDx)

    461 followers

  3. Milestone

    Website domain registered

    mirvie.com

  4. Milestone

    Company founded

    South San Francisco, United States

Investors & Backers

12
Allyson Felix
BlackRock
Comerica Bank
Correlation Ventures
Decheng Capital
Foresite Capital
General Catalyst
GV
Khosla Ventures
Mayfield Fund
Portfolia
Synetro Group

Funding History

1 Round
Series-B+ · May 17, 2022

Founders & Leadership

3

Maneesh Jain

Chief Executive Officer & Co-Founder

Work email & phone locked Unlock →

Manfred Lee

COO

Work email & phone locked Unlock →

Stephen Quake

Scientific Advisory Board Chair & Co-Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts